Envista Holdings
NVST
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
3
In their latest 13F (Q3 2026)
See who
Value held
$120m
Combined value at quarter end
Last quarter
1 bought
3 sold or trimmed
Fund portfolios
1
Funds holding it
See which
Price at Q2 ’26 end
$26.35
+3.9% in the quarter
Share price change by quarter
+18.8%Q3 ’24
-2.4%Q4 ’24
-10.5%Q1 ’25
+13.2%Q2 ’25
+4.2%Q3 ’25
+6.6%Q4 ’25
+16.9%Q1 ’26
+3.9%Q2 ’26
Managers holding it, by quarter
1Q4 ’23
2Q1 ’24
2Q2 ’24
2Q3 ’24
2Q4 ’24
2Q1 ’25
2Q2 ’25
3Q3 ’25
3Q4 ’25
4Q1 ’26
3Q2 ’26
0Q3 ’26
Who holds it
| Tweedy, Browne | 2.9%$37.8m | Trimmed -0.1% |
| Harris Associates (Oakmark) | 0.1%$72.6m | Trimmed -15% |
| First Eagle Investment Management | 0.0%$9.8m | Added +41% |
Directors buying and selling
How this works
| Bought or sold | ||||
|---|---|---|---|---|
| 20 Aug 2026 | Reis MischaSVP, Strategy & Bus. Dev. | ▼ Sold | 8,000 | $220k |
About the company
- Sector
- Health care · Dental Equipment & Supplies
- Incorporated in
- Delaware
- Financial year ends
- 31 December
- Shares outstanding
- 161m at 31 Jul 2026
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
$2.8bn2017
$2.8bn2018
$2.3bn2019
$1.9bn2020
$2.5bn2021
$2.6bn2022
$2.6bn2023
$2.5bn2024
$2.7bn2025
| Year | Revenue | Net income |
|---|---|---|
| 2025 | $2.7bn | $47.0m |
| 2024 | $2.5bn | −$1.1bn |
| 2023 | $2.6bn | −$100m |
| 2022 | $2.6bn | $243m |
| 2021 | $2.5bn | $341m |
| 2020 | $1.9bn | $33.3m |
| 2019 | $2.3bn | $218m |
| 2018 | $2.8bn | $231m |
| 2017 | $2.8bn | $301m |
Sold out last quarter
- First Pacific Advisors (FPA) in Q2 2026
In fund portfolios
| Oakmark Global FundHarris Associates (Oakmark) | 1.9% |